ce‐Subpathway: Identification of ceRNA‐mediated subpathways via joint power of ceRNAs and pathway topologies

Competing endogenous RNAs (ceRNAs) represent a novel mechanism of gene regulation that may mediate key subpathway regions and contribute to the altered activities of pathways. However, the classical methods used to identify pathways fail to specifically consider ceRNAs within the pathways and key regions impacted by them. We proposed a powerful strategy named ce‐Subpathway for the identification of ceRNA‐mediated functional subpathways. It provided an effective level of pathway analysis via integrating ceRNAs, differentially expressed (DE) genes and their key regions within the given pathways. We respectively analysed one pulmonary arterial hypertension (PAH) and one myocardial infarction (MI) data sets and demonstrated that ce‐Subpathway could identify many subpathways whose corresponding entire pathways were ignored by those non‐ceRNA‐mediated pathway identification methods. And these pathways have been well reported to be associated with PAH/MI‐related cardiovascular diseases. Further evidence showed reliability of ceRNA interactions and robustness/reproducibility of the ce‐Subpathway strategy by several data sets of different cancers, including breast cancer, oesophageal cancer and colon cancer. Survival analysis was finally applied to illustrate the clinical application value of the ceRNA‐mediated functional subpathways using another data sets of pancreatic cancer. Comprehensive analyses have shown the power of a joint ceRNAs/DE genes and subpathway strategy based on their topologies.

[1]  Meng Li,et al.  Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways , 2016, Scientific Reports.

[2]  M. Mann,et al.  Cell cycle progression: new therapeutic target for vascular proliferative disease. , 1998, Circulation.

[3]  Christopher S. Law,et al.  Vitamin D-dependent suppression of endothelin-induced vascular smooth muscle cell proliferation through inhibition of CDK2 activity , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[5]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.

[6]  Tong Zhang,et al.  The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.

[7]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[9]  Chunquan Li,et al.  SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.

[10]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[11]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[12]  Carlotta Costa,et al.  PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1 , 2013, Proceedings of the National Academy of Sciences.

[13]  Jack R. Takahashi,et al.  PDGF‐dependent β‐catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension , 2016, FEBS letters.

[14]  Carlos L Arteaga,et al.  Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer , 2011, Breast Cancer Research.

[15]  S. Chakrabarti,et al.  Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. , 2010, American journal of physiology. Endocrinology and metabolism.

[16]  J. Eyfjörd,et al.  Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients’ Clinical Outcome , 2014, PloS one.

[17]  M. Pellegrino,et al.  STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration , 2013, Molecular and Cellular Neuroscience.

[18]  Jian Zhang,et al.  Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy , 2016, Oncotarget.

[19]  P. Crespo,et al.  The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway , 1995, Cell.

[20]  Trey Ideker,et al.  Integrating physical and genetic maps: from genomes to interaction networks , 2007, Nature Reviews Genetics.

[21]  Xuerui Yang,et al.  An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.

[22]  Anandita Rajpurohit,et al.  PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System , 2013, Clinical Cancer Research.

[23]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[24]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[25]  C. Giachetti,et al.  Inhibition of c‐Jun N‐terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats , 2004, British journal of pharmacology.

[26]  X. Tong,et al.  Phosphorylation of MCM3 Protein by Cyclin E/Cyclin-dependent Kinase 2 (Cdk2) Regulates Its Function in Cell Cycle* , 2011, The Journal of Biological Chemistry.

[27]  A. Buda,et al.  Cytoskeletal network in colon cancer: from genes to clinical application. , 2004, The international journal of biochemistry & cell biology.

[28]  V. Golubovskaya,et al.  Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy , 2013, Cancer biology & therapy.

[29]  Qiwei Yang,et al.  Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1. , 2012, American journal of respiratory cell and molecular biology.

[30]  Integrated approach to evaluating coronary artery disease and ischemic heart disease. , 2002, The American journal of cardiology.

[31]  L. Ellis,et al.  Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells* , 2002, The Journal of Biological Chemistry.

[32]  Sorin Draghici,et al.  SPATIAL: A System-level PAThway Impact AnaLysis approach , 2016, Nucleic acids research.

[33]  M. Dinger,et al.  Endogenous microRNA sponges: evidence and controversy , 2016, Nature Reviews Genetics.

[34]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[35]  D. Rodman,et al.  Mevastatin Can Cause G1 Arrest and Induce Apoptosis in Pulmonary Artery Smooth Muscle Cells Through a p27Kip1-Independent Pathway , 2003, Circulation research.

[36]  Punam Malik,et al.  Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells. , 2011, The Biochemical journal.

[37]  V. Roger,et al.  Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. , 2009, Journal of the American College of Cardiology.

[38]  L. Leng,et al.  Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. , 2009, The Journal of clinical investigation.

[39]  Guo-qiang Kong,et al.  A computationally constructed ceRNA interaction network based on a comparison of the SHEE and SHEEC cell lines , 2016, Cellular & Molecular Biology Letters.

[40]  Ferdinando Di Cunto,et al.  Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.

[41]  Ferhaan Ahmad,et al.  E2F3 plays an essential role in cardiac development and function , 2008, Cell cycle.

[42]  Zhiping Weng,et al.  Identification of functional modules that correlate with phenotypic difference: the influence of network topology , 2010, Genome Biology.

[43]  P. Stiegler,et al.  RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. , 2001, Cancer research.

[44]  Yuan Yuan,et al.  Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway , 2012, Basic Research in Cardiology.

[45]  Qianlan Yao,et al.  Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways , 2013, Nucleic acids research.